ezogabine has been researched along with bupivacaine in 2 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (bupivacaine) | Trials (bupivacaine) | Recent Studies (post-2010) (bupivacaine) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 12,968 | 4,843 | 3,530 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friederich, P; Punke, MA | 1 |
| Chen, Y; Cheng, Y; Duan, R; Li, H; Li, J; Yuan, J; Zhao, S | 1 |
2 other study(ies) available for ezogabine and bupivacaine
| Article | Year |
|---|---|
Retigabine stimulates human KCNQ2/Q3 channels in the presence of bupivacaine.
Topics: Anesthetics, Local; Animals; Bupivacaine; Carbamates; CHO Cells; Cricetinae; Humans; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Kinetics; Membrane Potentials; Neurotoxicity Syndromes; Patch-Clamp Techniques; Phenylenediamines; Potassium Channels; Potassium Channels, Voltage-Gated | 2004 |
Effectiveness of retigabine against levobupivacaine-induced central nervous system toxicity: a prospective, randomized animal study.
Topics: Animals; Anticonvulsants; Bupivacaine; Carbamates; Central Nervous System; KCNQ2 Potassium Channel; Levobupivacaine; Neurons; Phenylenediamines; Prospective Studies; Rabbits; Random Allocation; Seizures | 2016 |